Conway Capital Management, Inc. Shockwave Medical, Inc. Transaction History

Conway Capital Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Dec 02, 2024	SELL	$0.0 - $334.83 $0 - $217,639	-650 Closed	0 $0
Q1 2024 Dec 02, 2024	BUY	$191.17 - $325.63 $124,260 - $211,659	650 New	650 $212 Million
Q3 2023 Dec 02, 2024	SELL	$194.33 - $283.97 $342,020 - $499,787	-1,760 Closed	0 $0
Q2 2023 Dec 02, 2024	BUY	$223.05 - $302.68 $109,294 - $148,313	490 Added 38.58%	1,760 $502 Million
Q1 2023 Dec 02, 2024	BUY	$175.41 - $217.92 $26,311 - $32,687	150 Added 13.39%	1,270 $275 Million
Q4 2022 Dec 02, 2024	SELL	$204.38 - $296.82 $197,226 - $286,431	-965 Reduced 46.28%	1,120 $230 Million
Q3 2022 Dec 02, 2024	BUY	$195.21 - $310.53 $407,012 - $647,455	2,085 New	2,085 $580 Million
Q1 2022 Dec 02, 2024	SELL	$127.96 - $207.36 $202,816 - $328,665	-1,585 Closed	0 $0
Q4 2021 Dec 02, 2024	SELL	$165.13 - $241.83 $236,961 - $347,026	-1,435 Reduced 47.52%	1,585 $283 Million
Q3 2021 Dec 02, 2024	BUY	$163.99 - $235.57 $214,826 - $308,596	1,310 Added 76.61%	3,020 $622 Million
Q2 2021 Dec 02, 2024	BUY	$131.45 - $201.49 $224,779 - $344,547	1,710 New	1,710 $324 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Conway Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Conway Capital Management, Inc. with notifications on news.